Cargando…

Genotypic resistance profiles in Chinese patients with chronic hepatitis B virus infection and the efficacy of nucleoside analog rescue therapy

BACKGROUND AND AIMS: The aims of this study were to explore the correlation between chronic hepatitis B virus (HBV) drug-resistant mutation profiles and the efficacy of nucleoside analog rescue therapy in patients with initial antiviral treatment failure. PATIENTS AND METHODS: Patients with initial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Ling-Bo, Chen, Lan-Lan, Chen, En-Qiang, Liao, Juan, Tang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362983/ https://www.ncbi.nlm.nih.gov/pubmed/25792840 http://dx.doi.org/10.2147/TCRM.S78128

Ejemplares similares

Efficacy of different nucleoside analog rescue therapies for entecavir-resistant chronic hepatitis B patients
por: Shang, Jin, et al.
Publicado: (2021)

Antiviral nucleoside analogs
por: Kataev, Vladimir E., et al.
Publicado: (2021)

Repurposing Nucleoside Analogs for Human Coronaviruses
por: Zandi, Keivan, et al.
Publicado: (2020)

Nucleoside Analogs with Fleximer Nucleobase
por: Chudinov, Mikhail V.
Publicado: (2020)

The nucleoside analog clitocine is a potent and efficacious readthrough agent
por: Friesen, Westley J., et al.
Publicado: (2017)

Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy
por: Stevaert, Annelies, et al.
Publicado: (2022)

New insights into the synergism of nucleoside analogs with radiotherapy
por: Lee, Michael W, et al.
Publicado: (2013)

Low-level viremia in nucleoside analog-treated chronic hepatitis B patients
por: Zhang, Qian, et al.
Publicado: (2021)

Adherence to Treatment with Oral Nucleoside/Nucleotide Analogs in Patients with Chronic Hepatitis B
por: Ozyigitoglu, Derya, et al.
Publicado: (2022)

Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B
por: Lei, Jun, et al.
Publicado: (2013)

Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study
por: Yan, Li-Bo, et al.
Publicado: (2016)

Nucleoside analogs assisted with Chinese compound prescription in treating hepatic fibrosis of chronic hepatitis B patients: A protocol of systematic review and meta-analysis
por: Cheng, Maoyuan, et al.
Publicado: (2020)

Prognostic factors in patients with hepatitis B virus-related hepatocellular carcinoma undergoing nucleoside analog antiviral therapy
por: NISHIKAWA, HIROKI, et al.
Publicado: (2013)

Nucleoside analogs NM107 and AT-527 are antiviral against rubella virus
por: Dittmar, Mark, et al.
Publicado: (2023)

Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study
por: Tao, Ya-Chao, et al.
Publicado: (2018)

Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice.
por: Schäfer, Alexandra, et al.
Publicado: (2021)

Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
por: Borbone, Nicola, et al.
Publicado: (2021)

Effects of dyslipidemia on E antigen seroconversion of patients with chronic hepatitis B treated by nucleoside (acid) analogs
por: Xia, Ziqiang, et al.
Publicado: (2021)

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
por: Kozielewicz, Dorota, et al.
Publicado: (2015)

Diverse models for anti-HIV activity of purine nucleoside analogs
por: Khatri, Naveen, et al.
Publicado: (2015)

Entrapment of DNA topoisomerase-DNA complexes by nucleotide/nucleoside analogs
por: Gmeiner, William H.
Publicado: (2019)

Synthesis of Sugar and Nucleoside Analogs and Evaluation of Their Anticancer and Analgesic Potentials
por: Hussain, Fahad, et al.
Publicado: (2022)

Nucleoside Analogs: A Review of Its Source and Separation Processes
por: Wang, Pan, et al.
Publicado: (2023)

Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study
por: Yang, Dan-Hong, et al.
Publicado: (2021)

Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants
por: Lam, Angela M., et al.
Publicado: (2017)

Successful Nucleoside Analog and Corticosteroid Therapy for Chronic Inflammatory Demyelinating Polyneuropathy in a Patient With Hepatitis B Virus Liver Cirrhosis
por: Nugraha, Eka Surya, et al.
Publicado: (2021)

Enantioselective Synthesis of Homo-N-Nucleosides Containing a 1,4-Dioxane Sugar Analog
por: Yu, Qiang, et al.
Publicado: (2008)

HIV-1 Polymerase Inhibition by Nucleoside Analogs: Cellular- and Kinetic Parameters of Efficacy, Susceptibility and Resistance Selection
por: von Kleist, Max, et al.
Publicado: (2012)

Targeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog Fludarabine
por: Koduvayur, Sujatha P., et al.
Publicado: (2016)

Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis
por: Pedersen, Niels C, et al.
Publicado: (2019)

Novel L-nucleoside analog, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia
por: Bankar, Aniket, et al.
Publicado: (2019)

Synergistic antitumor effect of adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase and nucleoside analogs for human breast carcinoma in vitro and in vivo
por: Tang, Miao, et al.
Publicado: (2015)

Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B
por: Wang, Fa-Da, et al.
Publicado: (2022)

The truncated mutant HBsAg expression increases the tumorigenesis of hepatitis B virus by regulating TGF-β/Smad signaling pathway
por: Wang, Meng-Lan, et al.
Publicado: (2018)

Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathy
por: Chang, Ching-Pang, et al.
Publicado: (2021)

Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results
por: Oey, Abbie, et al.
Publicado: (2023)

Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus
por: Deval, Jerome, et al.
Publicado: (2014)

Identification of Structural and Molecular Features Involved in the Transport of 3′-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3
por: Rahman, MD Fazlur, et al.
Publicado: (2018)

Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus‐related hepatocellular carcinoma after surgical resection: A multicenter study
por: Qi, Weili, et al.
Publicado: (2021)

Evaluation of Nucleoside Analogs as Antimicrobials Targeting Unique Enzymes in Borrelia burgdorferi
por: Chakraborti, Monideep, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3tj28i42u2t48ks634agrmut0p